Yahoo Web Search

  1. SRPT increased 17.1% on Jun 28 after Pfizer PFE announced initial data from its phase Ib study evaluating gene therapy candidate, PF-06939926, as a treatment for Duchenne muscular dystrophy ...

  2. In the phase Ib study, two doses of PF-06939926 were tested in six boys with DMD aged 6 to 12 years. Pfizer said that no other participants will be dosed until specific additional safety ...

  3. This week, there were several pipeline and regulatory updates from Pfizer PFE. Meanwhile, the Committee for Medicinal Products for Human Use (“CHMP”) of the European Medicines Agency gave positive ...

  4. Aethlon Medical (AEMD) reported financial results for their fiscal fourth quarter ending March 31, 2019 and provided a business update. Revenue of $80k was recorded in the quarter, representing ...

  5. Pfizer Inc. PFE announced top-line results from a late-stage study, which evaluated its PDE4 inhibitor, Eucrisa (crisaborole ointment, 2%), for the treatment of mild to moderate atopic dermatitis ...

  6. Eye Drops Moisturizing Twin Pack, Sodium Chloride Ophthalmic Ointment 5 percent Hypertonicity Eye Ointment, Sodium Chloride Ophthalmic Solution, 5 percent Hypertonicity Eye Drops and Lubricant ...

  7. Planet Fitness Inc's (NYSE: PLNT) stock has been added to the Russell 1000 Index and removed from the Russell 2000 Index. The pullback in the company's stock due to this Russell rebalancing ...

  8. NEW YORK & PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–DFB Healthcare Acquisitions Corp. (“DFB”) (NASDAQ: DFBH, DFBHU, DFBHW), a special purpose acquisition company sponsored by Deerfield Management ...

  9. Sarepta vs Pfizer: Which Stock Should Investors Buy?

    TipRanks via Yahoo FinanceJul 17 11:43 AM

    Sarepta Therapeutics, Inc. (SRPT) got a major boost in June after Pfizer, Inc. (PFE) presented data on its new Duchenne Muscular Dystrophy (DMD) gene therapy drug at the annual Parent Project ...

  10. 13 Real People Share Why It Was Totally Worth Splurging on Their Wedding

    GOBankingRates via Yahoo FinanceJul 19 16:00 PM

    Whether it’s worth spending tens of thousands of dollars on an extravagant wedding — or opting for cheaper nuptials — is up for fierce debate. “It was the only aspect of wedding planning Josh ...

  1. Ad
    related to PF